索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]任蕾,张鸿青.强化降压对高血压患者的影响[J].国际心血管病杂志,2021,02:87-90.
点击复制

强化降压对高血压患者的影响(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2021年02期
页码:
87-90
栏目:
综述
出版日期:
2021-03-20

文章信息/Info

Title:
-
作者:
任蕾; 张鸿青
650000 昆明市第一人民医院心内科
Author(s):
-
关键词:
强化降压;  标准降压;  高血压
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2021.02.006
文献标识码:
-
摘要:
随着各国降压指南的修订,强化降压方案广泛应用。该文概括了强化降压对伴随心血管疾病、动脉硬化、脑卒中和慢性肾病高血压患者的影响,介绍了部分国家降压指南推荐的强化降压方案和适应人群。
Abstract:
-

参考文献/References

[1] Rapsomaniki E, Timmis A, George J, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people[J]. Lancet, 2014, 383(9932):1899-1911.
[2] Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension[J]. Eur Heart J, 2018, 39(33):3021-3104.
[3] Torlasco C, Faini A, Makil E, et al. Cardiovascular risk and hypertension control in Italy. Data from the 2015 world hypertension day[J]. Int J Cardiol, 2017, 243:529-532.
[4] Group AS, Cushman WC, Evans GW, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus[J]. N Engl J Med, 2010, 362(17):1575-1585.
[5] Group SR, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control[J]. N Engl J Med, 2015, 373(22):2103-2116.
[6] Kajimoto K, Sato N, Takano T, et al. Association of age and baseline systolic blood pressure with outcomes in patients hospitalized for acute heart failure syndromes[J]. Int J Cardiol, 2015, 191:100-106.
[7] Sun X, Guo Y, Nie Z, et al. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial(SPRINT)[J]. Clin Res Cardiel, 2019, 108(3):273-281.
[8] Emini Veseli B, Perrotta P, De Meyer GRA, et al. Animal models of atherosclerosis[J]. Eur J Pharmacol, 2017, 816:3-13.
[9] Ketelhuth DF, Hansson GK. Adaptive response of T and B cells in atherosclerosis[J]. Circ Res, 2016, 118(4):668-678.
[10] McMaster WG, Kirabo A, Madhur MS, et al. Inflammation, immunity, and hypertensive end-organ damage[J]. Circ Res, 2015, 116(6):1022-1033.
[11] Kim HL, Kim SH. Pulse wave velocity in atherosclerosis[J]. Front Cardiovasc Med, 2019, 6:41.
[12] O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective[J]. J Am Coll Cardiol, 2007, 50(1):1-13.
[13] Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension[J]. JAMA, 2012, 308(9):875-881.
[14] Safar ME, Toto-Moukouo JJ, Bouthier JA, et al. Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment[J]. Circulation, 1987, 75(1 Pt 2):156-161.
[15] Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study[J]. Circulation, 2006, 113(5):657-663.
[16] Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham heart study[J]. Circulation, 2010, 121(4):505-511.
[17] Teixeira R, Vieira MJ, Goncalves A, et al. Ultrasonographic vascular mechanics to assess arterial stiffness: a review[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(3):233-246.
[18] Ichihara A, Hayashi M, Koura Y, et al. Long-term effects of intensive blood-pressure lowering on arterial wall stiffness in hypertensive patients[J]. Am J Hypertens, 2003, 16(11 Pt 1):959-965.
[19] Writing Group M, Mozaffarian D, Benjamin EJ, et al. Executive summary: heart disease and stroke statistics--2016 update: a report from the American Heart Association[J]. Circulation, 2016, 133(4):447-454.
[20] Lackland DT, Roccella EJ, Deutsch AF, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association[J]. Stroke, 2014, 45(1):315-353.
[21] Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review[J]. Stroke, 2003, 34(11):2741-2748.
[22] Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines[J]. Hypertension, 2018, 71(6):e13-e115.
[23] Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report[J]. JAMA, 2003, 289(19):2560-2572.
[24] Lekoubou A, Bishu KG, Ovbiagele B. Nationwide impact of the 2017 American College of Cardiology/American Heart Association blood pressure guidelines on stroke survivors[J]. J Am Heart Assoc, 2018, 7(12):e008548.
[25] Group SPSS, Benavente OR, Coffey CS, et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial[J]. Lancet, 2013, 382(9891):507-515.
[26] Croall ID, Tozer DJ, Moynihan B, et al. Effect of standard vs intensive blood pressure control on cerebral blood flow in small vessel disease: The PRESERVE randomized clinical trial[J]. JAMA neurology, 2018, 75(6):720-727.
[27] Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group[J]. N Engl J Med, 1994, 330(13):877-884.
[28] Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?[J]. Arch Intern Med, 2000, 160(5):685-693.
[29] Apperloo AJ, de Zeeuw D, de Jong PE. A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function[J]. Kidney Int, 1997, 51(3):793-797.
[30] Malhotra R, Craven T, Ambrosius WT, et al. Effects of intensive blood pressure lowering on kidney tubule injury in CKD: a longitudinal subgroup analysis in SPRINT[J]. Am J Kidney Dis, 2019, 73(1):21-30.
[31] Chang AR, Lóser M, Malhotra R, et al. Blood pressure goals in patients with CKD: a review of evidence and gGuidelines[J].Clin J Am Soc Nephrol, 2019, 14(1):161-169.
[32] Unger T, Borghi C, Charchar F, et al. 2020 International society of hypertension global hypertension practice guidelines[J]. J Hypertens, 2020, 38(6):982-1004.
[33] Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension(JSH 2019)[J]. Hypertens Res, 2019, 42(9):1235-1481.
[34] 中国高血压防治指南修订委员会, 高血压联盟(中国), 中华医学会心血管病学分会. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1):24-56.
[35] Sheng CS, Liu M, Kang YY, et al. Prevalence, awareness, treatment and control of hypertension in elderly Chinese[J]. Hypertens Res, 2013, 36(9):824-828.

备注/Memo

备注/Memo:
基金项目:昆明市卫生健康委员会委项目(2019-03-01-013)
通信作者:张鸿青,E-mail:15877990978@163.com
更新日期/Last Update: 2021-03-20